Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules

NEXT STORY
Predictive Oncology Announces $7.4 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
PREV STORY
Iterum Therapeutics plc Announces Exercise of Underwriter’s Option to Purchase Additional Ordinary Shares
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cyclacel Pharmaceuticals Prices $12.65 Million Underwritten Public Offering of Common Stock

author_avatar
NASDAQ Market News

Eurobio Scientific acquires Dendritics, a company specializing in antibody development and manufacture

Eurobio Scientific acquires Dendritics,  a company specializing in antibody development and manufacture This strategic ...

author_avatar
NASDAQ Market News

Dr. William Chey Highlights Unmet Medical Need of Lactose Intolerance and Potential for Phase 3 Drug Candidate RP-G28 in Expert Call Hosted by Ritter Pharmaceuticals

author_avatar
NASDAQ Market News